Orator: Prof. S.K. Sarin sir — Speech on ACLF of MAFLD
APASL Single Topic Conference, Dhaka 2026
Theme: MAFLD — Evidence-Based and Multidisciplinary Approach in the Era of Targeted Therapy
📅 5–6 December 2026
DAY 1 — Saturday, 5 December 2026
08:00–08:30
REGISTRATION
SESSION 1 | 08:30–09:30
"Setting the Scene — What Is MAFLD, Who Has It, and Why Should Every Doctor Care?"
- 1.1 The Fatty Liver Continuum: A Paradigm Shift in Reframing Management as a Lifetime Metabolic Priority
- 1.2 MAFLD: Why Asia-Pacific Patients Progress Differently
- 1.3 "But My Patient Is Thin": Lean MAFLD
SESSION 2 | 09:30–10:30
"Behind the Scenes — Mechanisms and Modern Diagnosis Without a Biopsy"
- 2.1 Pathogenesis of MAFLD : Simple Fatty liver to NASH–Cirrhosis–HCC
- 2.2 Non-Invasive Assessment of MAFLD
- 2.3 AI and Machine Learning in MAFLD: From Digital Pathology to Risk Prediction
10:30–11:00
TEA BREAK
SESSION 3 | 11:00–12:00
"One Patient, Many Doctors — Building a Multidisciplinary MAFLD Clinic"
- 3.1 Management of MAFLD by the Primary Care Physicians: What to Do, When to Refer, What Not to Miss
- 3.2 MAFLD and Type 2 Diabetes: Two-Way Screening and Shared Management
- 3.3 Cardiovascular Risk Management in MAFLD
12:00–13:30
3rd MOBIN KHAN MEMORIAL GOLD MEDAL ORATION
13:30–14:30
LUNCH & PRAYER BREAK — with FREE PAPER / DIGITAL POSTER VIEWING (Session 4 of 11)
SESSION 4 | 14:30–15:30
"Managing MAFLD in the Clinic"
- 4.1 Lifestyle Modification in MAFLD: How Much Weight Loss, Which Diet, How Much Exercise — Making It Work in Real Life
- 4.2 Resmetirom and Saroglitazar in the Management of MAFLD
- 4.3 Incretin-Based Therapy in Management of MAFLD
SESSION 5 | 15:30–16:30
"When MAFLD Turns Ugly — Cirrhosis, Portal Hypertension and HCC"
- 5.1 Progression of MAFLD to Cirrhosis: Natural History and Predicting Who Will Decompensate
- 5.2 HCC in MAFLD : With or without cirrhosis
- 5.3 Management of Portal Hypertension with MASH Cirrhosis
16:30–17:45
TEA BREAK
18:00–21:00
INAUGURAL CEREMONY
Cultural Program & Dinner (Day 1 closes at 21:00)
